Home > Healthcare > Biotechnology > Biotechnology R&D > Biological Sample Collection Kits Market

Biological Sample Collection Kits Market Trends

Report ID: GMI6002
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Biological Sample Collection Kits Market Trends

Ongoing R&D investments and innovations in biological sample collection kits are enhancing their ability to collect high-quality samples across various settings. These advancements support the growing need for personalized medicine and improve the efficiency of diagnostic and research processes.

Modern innovations ensure better preservation and stability of biological samples, which is essential for accurate analysis. By reducing the risk of sample degradation and contamination, these improvements lead to more reliable diagnostic and research outcomes.
Microfluidic technology, for instance, enables the precise collection and processing of small sample volumes. Devices utilizing this technology allow for painless finger-prick blood sampling with integrated processing capabilities. Similarly, dried blood spot (DBS) cards have benefited from advancements that improve the formulation of filter paper, enhancing the stability and recovery of analytes from dried blood spots. These cards simplify the collection and storage of blood samples at room temperature.
Furthermore, non-invasive saliva collection kits have also seen significant improvements, making them more reliable for detecting a broad range of biomarkers, including genetic material for DNA/RNA analysis and hormones for endocrinological studies. Collectively, these innovations contribute to the increased demand for biological sample collection kits in the market by improving sample quality, ease of collection, and analytical accuracy.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global biological sample collection kits industry was valued at USD 8.4 billion in 2023 and is expected to exhibit a CAGR of 8.8% from 2024 to 2032, driven by the increasing number of laboratory tests, fueled by rising chronic and infectious disease prevalence.

The hospitals and clinics segment is expected to grow at a pace of 8.7% between 2024-2032, as these settings experience a high volume of patient visits for a range of health issues, including acute and chronic conditions, routine check-ups, surgeries, and emergencies.

North America biological sample collection kits market accounted for USD 2.7 billion in 2023 and is anticipated to record a CAGR of 8.1% through 2032, owing to a high prevalence of chronic diseases, along with focus on regular monitoring and diagnostic testing.

Altona Diagnostics GmbH, Becton, Dickinson and Company, CTK Biotech, Inc., F. Hoffmann-La Roche Ltd, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America Holdings, Lucence Health Inc., and Puritan Medical Products among others.